E

Estrella Immunopharma
D

ESLA

1.24000
USD
0.18
(16.98%)
مغلق
حجم التداول
872
الربح لكل سهم
-0
العائد الربحي
-
P/E
-5
حجم السوق
50,020,731
المقالات

العنوان: Estrella Immunopharma

القطاع: Healthcare
الصناعة: Biotechnology
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.